Ely Benaim, Chief Medical Officer at NovoCure Ltd (NVCR), sold 8,410 shares at $65.16 ($531K) on 2022-05-10, disclosed to the SEC on 2022-05-12.
Open-market sale of $531k NVCR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.16 | 2,070 | $135K | 25.4% |
| 2 | $65.16 | 2,070 | $135K | 25.4% |
| 3 | $61.25 | 2,135 | $131K | 24.6% |
| 4 | $61.25 | 2,135 | $131K | 24.6% |
| Total | $63.17 avg | 8,410 | $531K | 100% |
| Filing → |
| NVCR | SELL | 2022-03-07 | $332K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $139K | — | Filing → |
| NVCR | SELL | 2021-08-03 | $367K | — | Filing → |